2’,3’,5’-Tri-O-benzoyl-2-thiouridine
2’,3’,5’-Tri-O-benzoyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[21052-18-6]
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/2-3-5-tri-o-benzoyl-2-thiouridine.html
Solubility
10 mM in DMSO
Smiles
O=C(C=CN1[C@@H]([C@H](OC(C2=CC=CC=C2)=O)[C@@H]3OC(C4=CC=CC=C4)=O)O[C@@H]3COC(C5=CC=CC=C5)=O)NC1=S
Molecular Formula
C30H24N2O8S
Molecular Weight
572.59
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
RFXANK (DNA-binding Protein RFXANK, Ankyrin Repeat Family A Protein 1, Regulatory Factor X Subunit B, RFX-B, Regulatory Factor X-associated Ankyrin-containing Protein, ANKRA1, RFXB, F14150_1, MGC138628) (HRP)
RFXANK (DNA-binding Protein RFXANK, Ankyrin Repeat Family A Protein 1, Regulatory Factor X Subunit B, RFX-B, Regulatory Factor X-associated Ankyrin-containing Protein, ANKRA1, RFXB, F14150_1, MGC138628) (HRP)
Lentiviral human VGLL1 shRNA (UAS) - Lentiviral human VGLL1 shRNA (UAS, GFP) plasmid
ZU5 (UNC5CL) (NM_173561) Human Tagged Lenti ORF Clone